Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BREAKING: Elon Musk Sells Nearly $4B In Tesla Shares In 3 Days

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk sold 19.5 million shares, estimated to be worth nearly $4 billion, in the electric vehicle maker between Nov. 4 and Nov. 8, filings made with the U.S. Securities and Exchange Commission show.
byBenzinga Overnight Desk
November 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

  • Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk sold 19.5 million shares, estimated to be worth nearly $4 billion, in the electric vehicle maker between Nov. 4 and Nov. 8, filings made with the U.S. Securities and Exchange Commission show.
  • Such a move is in line with analyst expectations, who predicted Musk would need to sell Tesla shares to fund his deal to acquire Twitter.
  • Tesla stock has been under tremendous pressure this week, plunging over 5% on Monday and nearly 3% again on Tuesday after a recall of 40,000 vehicles. The electric vehicle maker’s shares closed at $191.30, down 2.9%, intraday on Tuesday, according to data from Benzinga Pro.
  • This is a developing story. Follow for updates.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

CymaBay Therapeutics Announced Collaboration with Kaken Pharmaceutical to Develop and Commercialize Seladelpar in Japan for Primary Biliary Cholangitis; Kaken to Make Upfront Payment To Cymabay Of ~$34M Plus Milestone Payments Up To ~$128.4M And Royal…

By Charles Gross
January 8, 2:17 PM
CymaBay Therapeutics, Inc. (NASDAQ: CBAY) announced today that it has entered into a collaboration and license agreement with Kaken Pharmaceutical Co., Ltd. ("Kaken") for the development and commercialization in Japan of CymaBay's investigational drug seladelpar for the treatment of primary biliary cholangitis ("PBC").

CBAY